Cybin Inc. has announced that an Institutional Review Board has approved a Company-sponsored feasibility study using Kernel’s quantitative neuroimaging technology, Kernel Flow, to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics.
Category Press Release
Published in Businesswire